• About Us
    • Overview
    • Management Team
    • Advisory Board
    • Investors
    • Collaborations & Scientific Advisors
  • Science
    • Overview
    • Pipeline
  • News & Events
  • Menu Menu

ENA 2024

26 October 2024

EORTC-NCI-AACR SYMPOSIUM on molecular targets and cancer therapeutics

Barcelona, Spain
23-25 October 2024

Share this entry
  • Share on X
https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg 0 0 dSpeidel https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg dSpeidel2024-10-26 00:38:342024-09-17 17:40:23ENA 2024

MODULATING DNA DAMAGE RESPONSES TO CURE CANCER

Contact Us

Breakpoint Therapeutics GmbH
Essener Bogen 7
22419 Hamburg (Germany)

Telefon: +49 40 56081 180
E-mail: info@breakpointtx.com

Impressum

Registergericht: Hamburg
Registernummer: HRB 155717
Umsatzsteuer-Identifikationsnummer: DE 324 797 830

Geschäftsführer / Managing Directors
Dr. Daniel Speidel and Jonathan Hollick

Links

  • Privacy Statement
Breakpoint Therapeutics GmbH @ Website by FisherPaul
  • Privacy Statement
Breakpoint Therapeutics Announces Poster Presentation at the 36th EORTC-NCI-AACR...BIO-Europe 2024
Scroll to top